Compounds > triazoles
Page last updated: 2024-08-24

triazoles and Peripheral Nerve Diseases

triazoles has been researched along with Peripheral Nerve Diseases in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (41.67)29.6817
2010's4 (33.33)24.3611
2020's3 (25.00)2.80

Authors

AuthorsStudies
Xu, Y; Zhang, K1
Anderson, LD; Arazy, M; Auner, HW; Badros, A; Bahlis, NJ; Benjamin, R; Cavo, M; Chai, Y; Delimpasi, S; Dimopoulos, MA; Dolai, TK; Doronin, V; Facon, T; Garg, M; Gavriatopoulou, M; Grosicki, S; Hajek, R; Jagannath, S; Kauffman, MG; Kriachok, I; Leleu, X; Levy, M; Mateos, MV; Moreau, P; Pour, L; Pylypenko, H; Quach, H; Richardson, PG; Shacham, S; Shah, J; Simonova, M; Sinha, DK; Spicka, I; Stevens, DA; Usenko, G; Venner, CP1
Anderson, LD; Auner, HW; Bahlis, NJ; Beaumont, JL; Benjamin, R; Cavo, M; Chai, Y; Delimpasi, S; Dimopoulos, MA; Facon, T; Garg, MK; Grosicki, S; Hájek, R; Hudgens, S; Illmer, T; Jagannath, S; Kauffman, M; Kriachok, I; Leleu, X; Leong, H; Levy, M; Ma, X; Pour, L; Quach, H; Richardson, P; Sanchez, L; Shacham, S; Shah, J; Simonova, M; Sinha, DK; Špička, I; Stevens, DA; Tang, S; Usenko, G; Venner, C; Yu, H1
Albano, EA; Carver, AE; Porter, CC1
de La Blanchardière, A; de La Gastine, B; Fromager, G; Gendrot, A; Massias, L; Verdon, R1
Baxter, CG; Denning, DW; Felton, TW; Marshall, A; Roberts, M1
Björkholm, M; Celsing, F; Grane, P; Kalin, M1
Manji, H1
Holyoake, TL; McQuaker, IG; Osborne, WL; Parker, AN1
Demponeras, C; Kanta, E; Karandreas, N; Manesis, EK; Tsiodras, S; Zafiropoulou, R1
Imhof, A; Schaer, DJ; Schanz, U; Schwarz, U1
Amoiridis, G; Kalmanti, M; Kondi, A; Mantadakis, E1

Reviews

1 review(s) available for triazoles and Peripheral Nerve Diseases

ArticleYear
Toxic neuropathy.
    Current opinion in neurology, 2011, Volume: 24, Issue:5

    Topics: Alcoholic Neuropathy; Antifungal Agents; Antineoplastic Agents; Early Diagnosis; Humans; Peripheral Nervous System Diseases; Triazoles

2011

Trials

1 trial(s) available for triazoles and Peripheral Nerve Diseases

ArticleYear
Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone.
    American journal of hematology, 2021, 10-01, Volume: 96, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Dexamethasone; Female; Humans; Hydrazines; Male; Multiple Myeloma; Pain; Peripheral Nervous System Diseases; Triazoles

2021

Other Studies

10 other study(ies) available for triazoles and Peripheral Nerve Diseases

ArticleYear
Suppressing BRD4 exhibits protective effects against vincristine-induced peripheral neuropathy by alleviating inflammation and oxidative stress.
    Biochemical and biophysical research communications, 2020, 11-05, Volume: 532, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Azepines; Ganglia, Spinal; Gene Knockdown Techniques; Hyperalgesia; Macrophages; Male; Mice, Inbred C57BL; Mice, Mutant Strains; Nuclear Proteins; Pain; Peripheral Nervous System Diseases; Receptors, CCR2; Receptors, CXCR3; Sciatic Nerve; Transcription Factors; Triazoles; Vincristine

2020
Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma.
    American journal of hematology, 2021, 06-01, Volume: 96, Issue:6

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Clinical Trials, Phase III as Topic; Dexamethasone; Drug Administration Schedule; Female; Frailty; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hydrazines; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Peripheral Nervous System Diseases; Progression-Free Survival; Randomized Controlled Trials as Topic; Retrospective Studies; Severity of Illness Index; Triazoles

2021
Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X.
    Pediatric blood & cancer, 2009, Volume: 52, Issue:2

    Topics: Charcot-Marie-Tooth Disease; Child, Preschool; Drug Synergism; Female; Humans; Peripheral Nervous System Diseases; Pyrimidines; Triazoles; Vincristine; Voriconazole

2009
[Painful peripheral neuropathy associated with voriconazole during the treatment of chronic cavitary pulmonary aspergillosis].
    La Revue de medecine interne, 2010, Volume: 31, Issue:2

    Topics: Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Humans; Male; Pain; Peripheral Nervous System Diseases; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2010
Peripheral neuropathy in patients on long-term triazole antifungal therapy.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:9

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Cohort Studies; Female; Humans; Itraconazole; Long-Term Care; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult

2011
Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.
    Infection, 2012, Volume: 40, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Brain; Caspofungin; Cerebrum; Echinocandins; Humans; Larynx; Lipopeptides; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Neuroaspergillosis; Paranasal Sinuses; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Sweden; Tomography, X-Ray Computed; Triazoles; Voriconazole

2012
Fatal peripheral neuropathy following FLA chemotherapy.
    Clinical and laboratory haematology, 2004, Volume: 26, Issue:4

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Interactions; Fatal Outcome; Humans; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Triazoles; Vidarabine; Voriconazole

2004
Painful peripheral neuropathy associated with voriconazole use.
    Archives of neurology, 2005, Volume: 62, Issue:1

    Topics: Adult; Antifungal Agents; Female; Humans; Liver Transplantation; Neuralgia; Pain Measurement; Peripheral Nervous System Diseases; Pyrimidines; Triazoles; Voriconazole

2005
Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring.
    Swiss medical weekly, 2006, Nov-11, Volume: 136, Issue:45-46

    Topics: Adult; Antifungal Agents; Asthenia; Cognition Disorders; Dose-Response Relationship, Drug; Drug Monitoring; Female; Hallucinations; Humans; Irritable Mood; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Retrospective Studies; Sleep Initiation and Maintenance Disorders; Triazoles; Vision Disorders; Voriconazole

2006
Possible increase of the neurotoxicity of vincristine by the concurrent use of posaconazole in a young adult with leukemia.
    Journal of pediatric hematology/oncology, 2007, Volume: 29, Issue:2

    Topics: Adult; Antifungal Agents; Antineoplastic Agents; Demyelinating Diseases; Electromyography; Fever; Humans; Lung Diseases; Male; Neural Conduction; Neurotoxicity Syndromes; Neutropenia; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Triazoles; Vincristine

2007